Text and Data Mining valid from 2020-01-01
Received: 12 July 2019
Accepted: 12 December 2019
First Online: 1 January 2020
Compliance with ethical standards
: JEM and RAS are shareholders, and CBC, TRV, DAL and RAS are current employees of Stemmatters, Biotecnologia e Medicina Regenerativa SA. Stemmatters is currently developing a proprietary medical device to be used in the context of enhanced microfracture surgical treatment. Stemmatters is actively pursuing patents related to the content of the manuscript. This manuscript was not influenced by personal or financial relationship with Stemmatters or any other third party.
: This article does not contain any studies with human participants or animals performed by any of the authors.